PCR Technologies Global market - Forecast to 2022
Polymerase Chain Reaction (PCR) is a novel technique which doubles the amount of target DNA in every cycle. The PCR has three steps such as denaturation, annealing and extension, which are repeated in every cycle to achieve the product. PCR market has been divided as products, applications, techniques, end users and geography. PCR products market is further segmented into Instruments, reagents and consumables, software and services. In instruments there are traditional PCR’s and Real time PCR’s. Reagents and consumables are sub segmented into enzymes, dNTP’s, template DNA, primers and probes, buffers, master mixes, nuclease free water, consumable and others (tracking dye and wax beads). Software’s in the PCR market include Primer designers and sequence software’s, PCR data analysis software and others.
By application, the market is segmented into clinical diagnostics, industrial application, and others (Pathogen detection and dentistry). Clinical diagnostics are further divided into infectious and non infectious diseases. Infectious disease includes hepatitis B & C, tuberculosis, HIV and others. Non infectious diseases include prenatal diagnosis, tissue typing, cancer therapy, genetic typing for hereditary disease, blood screening and others. Industrial applications are divided into Agricultural, Environment, Applied testing, Animal husbandry, Biomedical research and other PCR industry applications. Applied testing includes forensic and food safety testing. Biomedical research includes DNA sequencing, genotyping, biomarker discovery, gene expression and genetic mapping, DNA cloning and others.
By Technique, the PCR market is segmented into standard PCR, real time PCR, reverse transcriptase PCR, digital PCR, assembly PCR, multiplex PCR, Hot start PCR and others. Others include nested PCR, Inverse PCR, Immune PCR, anchored PCR, RACE PCR, asymmetric PCR, universal PCR, ISSR PCR, allele specific PCR, ligation mediated PCR, touchdown PCR, solid phase PCR, methylation PCR, miniprimer PCR, nanoparticle assisted PCR, overlap extension PCR and In-situ PCR and long PCR. Based on the end- users PCR market is segmented into hospitals and laboratories, pharmaceuticals, CRO’s and biotech companies, academics and others (Blood banks).
Among the PCR technology products, Reagents & Consumables dominated the products market by occupying a largest share of XX%. At the same time, Reagents & Consumables market is the fastest growing segment from 2015 to 2022 with a CAGR of X% and is followed by services with a CAGR of XX%. In applications, the industry applications are the largest segment with XX% share and clinical diagnostics is expected to be the fastest growing segment from 2015 to 2022 with a CAGR of XX%. By end- users, Pharmaceuticals, CRO's and Biotech companies is the largest segment with a share of XX% and also, the fastest segment with a CAGR of XX% from 2015 to 2022. Geographical wise, North America is the largest market, with a share of XX% followed by Europe and Asia. The APAC region is the fastest growing region with a CAGR of XX% from 2015-2022 to reach $XX million.
The PCR technology market is expected to grow steadily at a CAGR of X% from 2015 to 2022. The factors driving the growth of this market are increasing demand for innovative technology supporting early and accurate diagnosis of life threatening disease, rising demand for PCR in genetic and molecular testing, expiry of key players PCR patents, rising investments in the field of companion diagnostics, advent of digital PCR, increasing RT PCR based food safety testing, increasing affinity for automated high throughput and robotic systems and multiplexed analytical strategies for improving sensitivity and speed of PCR technology. However, high cost of commercial PCR assays in the clinical diagnostics, lack of awareness and requirement of skilled labour and development of alternative technologies are some of the factors restraining PCR Technologies market.
The PCR technologies global market is a highly competitive and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Some of the Major players in the market are Abbott Laboratories, Inc., Inc. (U.S.), Agilent Technologies (U.S.), Becton, Dickinson and Company (U.S.), BioMerieux SA (France), Bio-Rad Laboratories, Inc. (U.S.), GE Healthcare (U.K.) ), Hoffmann la Roche (Switzerland), Merck KGaA (Germany), Promega Corporation (U.S.), Qiagen N.V. (Netherlands), Takara Bio, Inc.(Japan) and ThermoFisher Scientific, Inc. (U.S.).
The report provides an in depth market analysis of the above mentioned segments across the following regions:
By application, the market is segmented into clinical diagnostics, industrial application, and others (Pathogen detection and dentistry). Clinical diagnostics are further divided into infectious and non infectious diseases. Infectious disease includes hepatitis B & C, tuberculosis, HIV and others. Non infectious diseases include prenatal diagnosis, tissue typing, cancer therapy, genetic typing for hereditary disease, blood screening and others. Industrial applications are divided into Agricultural, Environment, Applied testing, Animal husbandry, Biomedical research and other PCR industry applications. Applied testing includes forensic and food safety testing. Biomedical research includes DNA sequencing, genotyping, biomarker discovery, gene expression and genetic mapping, DNA cloning and others.
By Technique, the PCR market is segmented into standard PCR, real time PCR, reverse transcriptase PCR, digital PCR, assembly PCR, multiplex PCR, Hot start PCR and others. Others include nested PCR, Inverse PCR, Immune PCR, anchored PCR, RACE PCR, asymmetric PCR, universal PCR, ISSR PCR, allele specific PCR, ligation mediated PCR, touchdown PCR, solid phase PCR, methylation PCR, miniprimer PCR, nanoparticle assisted PCR, overlap extension PCR and In-situ PCR and long PCR. Based on the end- users PCR market is segmented into hospitals and laboratories, pharmaceuticals, CRO’s and biotech companies, academics and others (Blood banks).
Among the PCR technology products, Reagents & Consumables dominated the products market by occupying a largest share of XX%. At the same time, Reagents & Consumables market is the fastest growing segment from 2015 to 2022 with a CAGR of X% and is followed by services with a CAGR of XX%. In applications, the industry applications are the largest segment with XX% share and clinical diagnostics is expected to be the fastest growing segment from 2015 to 2022 with a CAGR of XX%. By end- users, Pharmaceuticals, CRO's and Biotech companies is the largest segment with a share of XX% and also, the fastest segment with a CAGR of XX% from 2015 to 2022. Geographical wise, North America is the largest market, with a share of XX% followed by Europe and Asia. The APAC region is the fastest growing region with a CAGR of XX% from 2015-2022 to reach $XX million.
The PCR technology market is expected to grow steadily at a CAGR of X% from 2015 to 2022. The factors driving the growth of this market are increasing demand for innovative technology supporting early and accurate diagnosis of life threatening disease, rising demand for PCR in genetic and molecular testing, expiry of key players PCR patents, rising investments in the field of companion diagnostics, advent of digital PCR, increasing RT PCR based food safety testing, increasing affinity for automated high throughput and robotic systems and multiplexed analytical strategies for improving sensitivity and speed of PCR technology. However, high cost of commercial PCR assays in the clinical diagnostics, lack of awareness and requirement of skilled labour and development of alternative technologies are some of the factors restraining PCR Technologies market.
The PCR technologies global market is a highly competitive and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Some of the Major players in the market are Abbott Laboratories, Inc., Inc. (U.S.), Agilent Technologies (U.S.), Becton, Dickinson and Company (U.S.), BioMerieux SA (France), Bio-Rad Laboratories, Inc. (U.S.), GE Healthcare (U.K.) ), Hoffmann la Roche (Switzerland), Merck KGaA (Germany), Promega Corporation (U.S.), Qiagen N.V. (Netherlands), Takara Bio, Inc.(Japan) and ThermoFisher Scientific, Inc. (U.S.).
The report provides an in depth market analysis of the above mentioned segments across the following regions:
- North America
- Europe
- Asia-Pacific
- Rest of the World (RoW)
1 EXECUTIVE SUMMARY
2 INTRODUCTION
2.1 KEY TAKE AWAYS
2.2 REPORT DESCRIPTION
2.3 MARKETS COVERED
2.4 STAKEHOLDERS
2.5 RESEARCH METHODOLOGY
2.5.1 MARKET SIZE ESTIMATION
2.5.2 MARKET CRACKDOWN AND DATA TRIANGULATION
2.5.3 SECONDARY SOURCES
2.5.4 PRIMARY SOURCES
2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES
2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.5.7 ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.3.1 DRIVERS AND OPPORTUNITIES
3.3.1.1 Requirement of early detection of disease
3.3.1.2 Rising demand for PCR in genetic and molecular testing
3.3.1.3 Expiry of key players PCR patents
3.3.1.4 Rising investments in the field of companion diagnostics using pcr
3.3.1.5 Advent of digital PCR
3.3.1.6 Increasing RT-PCR based food safety testing
3.3.1.7 Increasing affinity for automated high throughput and robotic systems in PCR
3.3.1.8 Multiplexed analytical strategies for improving sensitivity and speed of PCR technology
3.3.1.9 Integration of technologies to be expected to accelerate the speed of DNA analysis processes using PCR
3.3.2 RESTRAINTS AND THREATS
3.3.2.1 High cost of commercial PCR assays in clinical diagnostics
3.3.2.2 Lack of awareness and requirement of skilled labor
3.3.2.3 Development of alternate technologies
3.3.2.4 Stringent regulatory framework
3.3.3 PROBLEM AREAS
3.3.3.1 PCR Patent analysis
3.3.4 WINNING IMPERATIVE
3.3.4.1 PCR Portability
3.4 REGULATORY AFFAIRS
3.4.1 U.S.
3.4.2 EUROPE
3.4.3 CHINA
3.4.4 INDIA
3.4.5 JAPAN
3.5 PORTER’S FIVE FORCE ANALYSIS
3.5.1 THREAT OF NEW ENTRANTS
3.5.2 THREAT OF SUBSTITUTES
3.5.3 RIVALRY AMONG EXISTING COMPETITORS
3.5.4 BARGAINING POWER OF SUPPLIERS
3.5.5 BARGAINING POWER OF BUYERS
3.6 SUPPLY CHAIN ANALYSIS
3.7 MARKET SHARE ANALYSIS BY MAJOR PLAYERS
3.8 PATENT TRENDS
4 GLOBAL PCR TECHNIQUES MARKET
4.1 INTRODUCTION
4.2 STANDARD PCR
4.3 REAL TIME PCR/QPCR
4.4 REVERSE TRANSCRIPTASE PCR
4.5 DIGITAL PCR
4.6 ASSEMBLY PCR
4.7 MULTIPLEX PCR
4.8 HOT START PCR
4.9 OTHERS
4.9.1 NESTED PCR
4.9.2 INVERSE PCR
4.9.3 IMMUNO PCR
4.9.4 LONG PCR
4.9.5 ANCHORED PCR
4.9.6 RAPID AMPLIFICATION OF CDNA ENDS (RACE) PCR
4.9.7 ASYMMETRIC PCR
4.9.8 UNIVERSAL PCR
4.9.9 INTER SEQUENCE-SPECIFIC PCR(ISSR-PCR)
4.9.10 ALLELE-SPECIFIC PCR
4.9.11 LIGATION MEDIATED PCR
4.9.12 TOUCHDOWN PCR
4.9.13 SOLID PHASE PCR
4.9.14 METHYLATION SPECIFIC PCR
4.9.15 MINIPRIMER PCR
4.9.16 NANOPARTICLE-ASSISTED PCR
4.9.17 OVERLAP EXTENSION PCR
4.9.18 IN SITU PCR
5 GLOBAL PCR PRODUCTS MARKET
5.1 INTRODUCTION
5.2 INSTRUMENTS
5.2.1 TRADITIONAL THERMOCYCLER
5.2.2 REAL TIME THERMOCYCLER
5.3 REAGENTS & CONSUMABLES
5.3.1 ENZYMES
5.3.2 DNTP’S
5.3.3 TEMPLATE DNA OR CONTROLS
5.3.4 PRIMERS AND PROBES
5.3.5 BUFFERS
5.3.6 MASTER MIXES
5.3.7 NUCLEASE FREE WATER
5.3.8 CONSUMABLES
5.3.9 OTHERS
5.4 SOFTWARE
5.4.1 PRIMER DESIGN AND SEQUENCING SOFTWARE
5.4.2 PCR DATA ANALYZER SOFTWARE
5.4.3 OTHERS
5.5 SERVICES
6 GLOBAL PCR APPLICATIONS MARKET
6.1 INTRODUCTION
6.2 CLINICAL DIAGNOSTICS
6.2.1 INFECTIOUS DISEASES
6.2.1.1 Hepatitis B and C testing
6.2.1.2 Tuberculosis diagnosis
6.2.1.3 HIV Diagnosis
6.2.1.4 Others
6.2.2 NON INFECTIOUS DISEASES
6.2.2.1 Prenatal diagnosis
6.2.2.2 Tissue typing
6.2.2.3 Cancer therapy
6.2.2.4 Genetic testing for hereditory diseases
6.2.2.5 Blood screening
6.2.2.6 Others
6.3 INDUSTRY APPLICATIONS
6.3.1 AGRICULTURAL BIOTECHNOLOGY
6.3.2 ENVIRONMENT
6.3.3 APPLIED TESTING
6.3.3.1 Forensics
6.3.3.2 Food safety testing
6.3.4 ANIMAL HUSBANDRY
6.3.5 BIOMEDICAL RESEARCH
6.3.5.1 DNA Sequencing
6.3.5.2 Genotyping
6.3.5.3 Biomarker discovery
6.3.5.4 Gene expression and genetic mapping
6.3.5.5 DNA Cloning
6.3.5.6 Other biomedical research applications
6.3.6 OTHER PCR INDUSTRIAL APPLICATIONS
6.4 OTHER PCR APPLICATIONS
6.4.1 PATHOGEN DETECTION
6.4.2 DENTISTRY
7 GLOBAL PCR END USERS MARKET
7.1 INTRODUCTION
7.2 HOSPITALS AND LABORATORIES
7.3 PHARMACEUTICALS, CRO’S AND BIOTECH COMPANIES
7.4 ACADEMICS
7.5 OTHERS
8 REGIONAL MARKET ANALYSIS
8.1 INTRODUCTION
8.2 NORTH AMERICA
8.2.1 U.S.
8.3 EUROPE
8.4 ASIA PACIFIC
8.5 REST OF THE WORLD
9 COMPANY DEVELOPMENTS
9.1 INTRODUCTION
9.1.1 NEW PRODUCT LAUNCHES AS MAJOR GROWTH STRATEGY OF PCR MARKET PLAYERS
9.2 NEW PRODUCT LAUNCH
9.3 APPROVALS
9.4 AGREEMENTS PARTERNER SHIPS, COLLABORATIONS & JOINT VENTURES
9.5 MERGERS AND ACQUISITION
9.6 OTHERS
10 MAJOR PLAYER PROFILES
10.1 ABBOTT LABORATORIES, INC.
10.1.1 OVERVIEW
10.1.2 FINANCIALS
10.1.3 PRODUCT PORTFOLIO
10.1.4 KEY DEVELOPMENTS
10.1.5 BUSINESS STRATEGY
10.1.6 SWOT ANALYSIS
10.2 AGILENT TECHNOLOGIES
10.2.1 OVERVIEW
10.2.2 FINANCIALS
10.2.3 PRODUCT PORTFOLIO
10.2.4 KEY DEVELOPMENTS
10.2.5 BUSINESS STRATEGY
10.2.6 SWOT ANALYSIS
10.3 BECTON DICKINSON AND COMPANY
10.3.1 OVERVIEW
10.3.2 FINANCIALS
10.3.3 PRODUCT PORTFOLIO
10.3.4 KEY DEVELOPMENTS
10.3.5 BUSINESS STRATEGY
10.3.6 SWOT ANALYSIS
10.4 BIOMERIEUX SA
10.4.1 OVERVIEW
10.4.2 FINANCIALS
10.4.3 PRODUCT PORTFOLIO
10.4.4 KEY DEVELOPMENTS
10.4.5 BUSINESS STRATEGY
10.4.6 SWOT ANALYSIS
10.5 BIO-RAD LABORATORIES
10.5.1 OVERVIEW
10.5.2 FINANCIALS
10.5.3 PRODUCT PORTFOLIO
10.5.4 KEY DEVELOPMENTS
10.5.5 BUSINESS STRATEGY
10.5.6 SWOT ANALYSIS
10.6 GE HEALTHCARE
10.6.1 OVERVIEW
10.6.2 FINANCIALS
10.6.3 PRODUCT PORTFOLIO
10.6.4 KEY DEVELOPMENTS
10.6.5 BUSINESS STRATEGY
10.6.6 SWOT ANALYSIS
10.7 HOFFMANN-LA ROCHE LTD.
10.7.1 OVERVIEW
10.7.2 FINANCIALS
10.7.3 PRODUCT PORTFOLIO
10.7.4 KEY DEVELOPMENTS
10.7.5 BUSINESS STRATEGY
10.7.6 SWOT ANALYSIS
10.8 MERCK KGAA
10.8.1 OVERVIEW
10.8.2 FINANCIALS
10.8.3 PRODUCT PORTFOLIO
10.8.4 KEY DEVELOPMENTS
10.8.5 BUSINESS STRATEGY
10.8.6 SWOT ANALYSIS
10.9 PROMEGA CORPORATION
10.9.1 OVERVIEW
10.9.2 FINANCIALS
10.9.3 PRODUCT PORTFOLIO
10.9.4 KEY DEVELOPMENTS
10.9.5 BUSINESS STRATEGY
10.9.6 SWOT ANALYSIS
10.10 QIAGEN N.V.
10.10.1 OVERVIEW
10.10.2 FINANCIALS
10.10.3 PRODUCT PORTFOLIO
10.10.4 KEY DEVELOPMENTS
10.10.5 BUSINESS STRATEGY
10.10.6 SWOT ANALYSIS
10.11 TAKARA BIO, INC.
10.11.1 OVERVIEW
10.11.2 FINANCIALS
10.11.3 PRODUCT PORTFOLIO
10.11.4 KEY DEVELOPMENTS
10.11.5 BUSINESS STRATEGY
10.11.6 SWOT ANALYSIS
10.12 THERMO FISHER SCIENTIFIC, INC.
10.12.1 OVERVIEW
10.12.2 FINANCIALS
10.12.3 PRODUCT PORTFOLIO
10.12.4 KEY DEVELOPMENTS
10.12.5 BUSINESS STRATEGY
10.12.6 SWOT ANALYSIS
2 INTRODUCTION
2.1 KEY TAKE AWAYS
2.2 REPORT DESCRIPTION
2.3 MARKETS COVERED
2.4 STAKEHOLDERS
2.5 RESEARCH METHODOLOGY
2.5.1 MARKET SIZE ESTIMATION
2.5.2 MARKET CRACKDOWN AND DATA TRIANGULATION
2.5.3 SECONDARY SOURCES
2.5.4 PRIMARY SOURCES
2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES
2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.5.7 ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.3.1 DRIVERS AND OPPORTUNITIES
3.3.1.1 Requirement of early detection of disease
3.3.1.2 Rising demand for PCR in genetic and molecular testing
3.3.1.3 Expiry of key players PCR patents
3.3.1.4 Rising investments in the field of companion diagnostics using pcr
3.3.1.5 Advent of digital PCR
3.3.1.6 Increasing RT-PCR based food safety testing
3.3.1.7 Increasing affinity for automated high throughput and robotic systems in PCR
3.3.1.8 Multiplexed analytical strategies for improving sensitivity and speed of PCR technology
3.3.1.9 Integration of technologies to be expected to accelerate the speed of DNA analysis processes using PCR
3.3.2 RESTRAINTS AND THREATS
3.3.2.1 High cost of commercial PCR assays in clinical diagnostics
3.3.2.2 Lack of awareness and requirement of skilled labor
3.3.2.3 Development of alternate technologies
3.3.2.4 Stringent regulatory framework
3.3.3 PROBLEM AREAS
3.3.3.1 PCR Patent analysis
3.3.4 WINNING IMPERATIVE
3.3.4.1 PCR Portability
3.4 REGULATORY AFFAIRS
3.4.1 U.S.
3.4.2 EUROPE
3.4.3 CHINA
3.4.4 INDIA
3.4.5 JAPAN
3.5 PORTER’S FIVE FORCE ANALYSIS
3.5.1 THREAT OF NEW ENTRANTS
3.5.2 THREAT OF SUBSTITUTES
3.5.3 RIVALRY AMONG EXISTING COMPETITORS
3.5.4 BARGAINING POWER OF SUPPLIERS
3.5.5 BARGAINING POWER OF BUYERS
3.6 SUPPLY CHAIN ANALYSIS
3.7 MARKET SHARE ANALYSIS BY MAJOR PLAYERS
3.8 PATENT TRENDS
4 GLOBAL PCR TECHNIQUES MARKET
4.1 INTRODUCTION
4.2 STANDARD PCR
4.3 REAL TIME PCR/QPCR
4.4 REVERSE TRANSCRIPTASE PCR
4.5 DIGITAL PCR
4.6 ASSEMBLY PCR
4.7 MULTIPLEX PCR
4.8 HOT START PCR
4.9 OTHERS
4.9.1 NESTED PCR
4.9.2 INVERSE PCR
4.9.3 IMMUNO PCR
4.9.4 LONG PCR
4.9.5 ANCHORED PCR
4.9.6 RAPID AMPLIFICATION OF CDNA ENDS (RACE) PCR
4.9.7 ASYMMETRIC PCR
4.9.8 UNIVERSAL PCR
4.9.9 INTER SEQUENCE-SPECIFIC PCR(ISSR-PCR)
4.9.10 ALLELE-SPECIFIC PCR
4.9.11 LIGATION MEDIATED PCR
4.9.12 TOUCHDOWN PCR
4.9.13 SOLID PHASE PCR
4.9.14 METHYLATION SPECIFIC PCR
4.9.15 MINIPRIMER PCR
4.9.16 NANOPARTICLE-ASSISTED PCR
4.9.17 OVERLAP EXTENSION PCR
4.9.18 IN SITU PCR
5 GLOBAL PCR PRODUCTS MARKET
5.1 INTRODUCTION
5.2 INSTRUMENTS
5.2.1 TRADITIONAL THERMOCYCLER
5.2.2 REAL TIME THERMOCYCLER
5.3 REAGENTS & CONSUMABLES
5.3.1 ENZYMES
5.3.2 DNTP’S
5.3.3 TEMPLATE DNA OR CONTROLS
5.3.4 PRIMERS AND PROBES
5.3.5 BUFFERS
5.3.6 MASTER MIXES
5.3.7 NUCLEASE FREE WATER
5.3.8 CONSUMABLES
5.3.9 OTHERS
5.4 SOFTWARE
5.4.1 PRIMER DESIGN AND SEQUENCING SOFTWARE
5.4.2 PCR DATA ANALYZER SOFTWARE
5.4.3 OTHERS
5.5 SERVICES
6 GLOBAL PCR APPLICATIONS MARKET
6.1 INTRODUCTION
6.2 CLINICAL DIAGNOSTICS
6.2.1 INFECTIOUS DISEASES
6.2.1.1 Hepatitis B and C testing
6.2.1.2 Tuberculosis diagnosis
6.2.1.3 HIV Diagnosis
6.2.1.4 Others
6.2.2 NON INFECTIOUS DISEASES
6.2.2.1 Prenatal diagnosis
6.2.2.2 Tissue typing
6.2.2.3 Cancer therapy
6.2.2.4 Genetic testing for hereditory diseases
6.2.2.5 Blood screening
6.2.2.6 Others
6.3 INDUSTRY APPLICATIONS
6.3.1 AGRICULTURAL BIOTECHNOLOGY
6.3.2 ENVIRONMENT
6.3.3 APPLIED TESTING
6.3.3.1 Forensics
6.3.3.2 Food safety testing
6.3.4 ANIMAL HUSBANDRY
6.3.5 BIOMEDICAL RESEARCH
6.3.5.1 DNA Sequencing
6.3.5.2 Genotyping
6.3.5.3 Biomarker discovery
6.3.5.4 Gene expression and genetic mapping
6.3.5.5 DNA Cloning
6.3.5.6 Other biomedical research applications
6.3.6 OTHER PCR INDUSTRIAL APPLICATIONS
6.4 OTHER PCR APPLICATIONS
6.4.1 PATHOGEN DETECTION
6.4.2 DENTISTRY
7 GLOBAL PCR END USERS MARKET
7.1 INTRODUCTION
7.2 HOSPITALS AND LABORATORIES
7.3 PHARMACEUTICALS, CRO’S AND BIOTECH COMPANIES
7.4 ACADEMICS
7.5 OTHERS
8 REGIONAL MARKET ANALYSIS
8.1 INTRODUCTION
8.2 NORTH AMERICA
8.2.1 U.S.
8.3 EUROPE
8.4 ASIA PACIFIC
8.5 REST OF THE WORLD
9 COMPANY DEVELOPMENTS
9.1 INTRODUCTION
9.1.1 NEW PRODUCT LAUNCHES AS MAJOR GROWTH STRATEGY OF PCR MARKET PLAYERS
9.2 NEW PRODUCT LAUNCH
9.3 APPROVALS
9.4 AGREEMENTS PARTERNER SHIPS, COLLABORATIONS & JOINT VENTURES
9.5 MERGERS AND ACQUISITION
9.6 OTHERS
10 MAJOR PLAYER PROFILES
10.1 ABBOTT LABORATORIES, INC.
10.1.1 OVERVIEW
10.1.2 FINANCIALS
10.1.3 PRODUCT PORTFOLIO
10.1.4 KEY DEVELOPMENTS
10.1.5 BUSINESS STRATEGY
10.1.6 SWOT ANALYSIS
10.2 AGILENT TECHNOLOGIES
10.2.1 OVERVIEW
10.2.2 FINANCIALS
10.2.3 PRODUCT PORTFOLIO
10.2.4 KEY DEVELOPMENTS
10.2.5 BUSINESS STRATEGY
10.2.6 SWOT ANALYSIS
10.3 BECTON DICKINSON AND COMPANY
10.3.1 OVERVIEW
10.3.2 FINANCIALS
10.3.3 PRODUCT PORTFOLIO
10.3.4 KEY DEVELOPMENTS
10.3.5 BUSINESS STRATEGY
10.3.6 SWOT ANALYSIS
10.4 BIOMERIEUX SA
10.4.1 OVERVIEW
10.4.2 FINANCIALS
10.4.3 PRODUCT PORTFOLIO
10.4.4 KEY DEVELOPMENTS
10.4.5 BUSINESS STRATEGY
10.4.6 SWOT ANALYSIS
10.5 BIO-RAD LABORATORIES
10.5.1 OVERVIEW
10.5.2 FINANCIALS
10.5.3 PRODUCT PORTFOLIO
10.5.4 KEY DEVELOPMENTS
10.5.5 BUSINESS STRATEGY
10.5.6 SWOT ANALYSIS
10.6 GE HEALTHCARE
10.6.1 OVERVIEW
10.6.2 FINANCIALS
10.6.3 PRODUCT PORTFOLIO
10.6.4 KEY DEVELOPMENTS
10.6.5 BUSINESS STRATEGY
10.6.6 SWOT ANALYSIS
10.7 HOFFMANN-LA ROCHE LTD.
10.7.1 OVERVIEW
10.7.2 FINANCIALS
10.7.3 PRODUCT PORTFOLIO
10.7.4 KEY DEVELOPMENTS
10.7.5 BUSINESS STRATEGY
10.7.6 SWOT ANALYSIS
10.8 MERCK KGAA
10.8.1 OVERVIEW
10.8.2 FINANCIALS
10.8.3 PRODUCT PORTFOLIO
10.8.4 KEY DEVELOPMENTS
10.8.5 BUSINESS STRATEGY
10.8.6 SWOT ANALYSIS
10.9 PROMEGA CORPORATION
10.9.1 OVERVIEW
10.9.2 FINANCIALS
10.9.3 PRODUCT PORTFOLIO
10.9.4 KEY DEVELOPMENTS
10.9.5 BUSINESS STRATEGY
10.9.6 SWOT ANALYSIS
10.10 QIAGEN N.V.
10.10.1 OVERVIEW
10.10.2 FINANCIALS
10.10.3 PRODUCT PORTFOLIO
10.10.4 KEY DEVELOPMENTS
10.10.5 BUSINESS STRATEGY
10.10.6 SWOT ANALYSIS
10.11 TAKARA BIO, INC.
10.11.1 OVERVIEW
10.11.2 FINANCIALS
10.11.3 PRODUCT PORTFOLIO
10.11.4 KEY DEVELOPMENTS
10.11.5 BUSINESS STRATEGY
10.11.6 SWOT ANALYSIS
10.12 THERMO FISHER SCIENTIFIC, INC.
10.12.1 OVERVIEW
10.12.2 FINANCIALS
10.12.3 PRODUCT PORTFOLIO
10.12.4 KEY DEVELOPMENTS
10.12.5 BUSINESS STRATEGY
10.12.6 SWOT ANALYSIS
LIST OF TABLES
Table 1 GLOBAL PCR TECHNOLOGIES MARKET, BY REGION, (2014-2022) ($MN)
Table 2 GLOBAL PCR TECHNOLOGIES MARKET, BY TECHNIQUES, (2014-2022) ($MN)
Table 3 GLOBAL PCR TECHNOLOGIES MARKET, BY PRODUCTS, (2014-2022) ($MN)
Table 4 GLOBAL PCR TECHNOLOGIES MARKET, BY APPLICATIONS, (2014-2022) ($MN)
Table 5 GLOBAL PCR TECHNOLOGIES MARKET , BY END-USERS, (2014-2022) ($MN)
Table 6 PCR GLOBAL MARKET , BY TECHNIQUES (2014-2022) ($MN)
Table 7 GLOBAL STANDARD PCR MARKET, BY GEOGRAPHY (2014-2022) ($MN)
Table 8 LIST OF INSTRUMENTS WITH COST AND FEATURES
Table 9 GLOBAL REAL TIME PCR/QPCR MARKET, BY GEOGRAPHY, (2014-2022) ($MN)
Table 10 GLOBAL REVERSE TRANSCRIPTASE PCR MARKET, BY GEOGRAPHY, (2014-2022) ($MN)
Table 11 LIST OF INSTRUMENTS AND THEIR COST FOR REACTION
Table 12 GLOBAL DIGITAL PCR MARKET, BY GEOGRAPHY, (2014-2022) ($MN)
Table 13 GLOBAL ASSEMBLY PCR MARKET, BY GEOGRAPHY, (2014-2022) ($MN)
Table 14 GLOBAL MULTIPLEX PCR MARKET, BY GEOGRAPHY (2014-2022) ($MN)
Table 15 GLOBAL HOT START PCR MARKET, BY GEOGRAPHY, (2014-2022) ($MN)
Table 16 GLOBAL OTHER PCR TECHNIQUES MARKET, BY GEOGRAPHY, (2014-2022) ($MN)
Table 17 GLOBAL PCR TECHNOLOGIES MARKET, BY PRODUCT TYPE, (2014-2022) ($MN)
Table 18 GLOBAL PCR INSTRUMENTS MARKET, BY REGION, (2014-2022) ($MN)
Table 19 GLOBAL PCR INSTRUMENTS MARKET, BY TYPE, (2014-2022) ($MN)
Table 20 GLOBAL PCR TRADITIONAL THERMOCYCLERS MARKET, BY REGION, (2014-2022) ($MN)
Table 21 GLOBAL PCR REAL TIME THERMOCYCLERS MARKET, BY REGION, (2014-2022) ($MN)
Table 22 GLOBAL PCR REAGENTS & CONSUMABLES MARKET, BY REGION, (2014-2022) ($MN)
Table 23 GLOBAL PCR REAGENTS & CONSUMABLES MARKET, BY TYPE, (2014-2022) ($MN)
Table 24 GLOBAL PCR ENZYMES MARKET, BY REGION, (2014-2022) ($MN)
Table 25 GLOBAL PCR DNTP’S MARKET, BY REGION, (2014-2022) ($MN)
Table 26 GLOBAL PCR TEMPLATES OR CONTROLS MARKET, BY REGION, (2014-2022) ($MN)
Table 27 GLOBAL PCR PRIMERS AND PROBES MARKET, BY REGION, (2014-2022) ($MN)
Table 28 GLOBAL PCR BUFFERS MARKET, BY REGION, (2014-2022) ($MN)
Table 29 GLOBAL PCR REAGENT KITS OR MASTER MIXES MARKET, BY REGION, (2014-2022) ($MN)
Table 30 GLOBAL PCR NUCLEASE FREE MARKET, BY REGION, (2014-2022) ($MN)
Table 31 GLOBAL PCR CONSUMABLES MARKET, BY REGION, (2014-2022) ($MN)
Table 32 GLOBAL PCR OTHER REAGENTS & CONSUMABLES MARKET, BY REGION, (2014-2022) ($MN)
Table 33 GLOBAL PCR SOFTWARE MARKET, BY REGION, (2014-2022) ($MN)
Table 34 GLOBAL PCR SOFTWARE MARKET, BY TYPE (2014-2022) ($MN)
Table 35 GLOBAL PCR PRIMER DESIGN AND SEQUENCING SOFTWARE MARKET, BY REGION, (2014-2022) ($MN)
Table 36 GLOBAL PCR DATA ANALYZER SOFTWARE MARKET, BY REGION, (2014-2022) ($MN)
Table 37 GLOBAL PCR OTHER SOFTWARES MARKET, BY REGION, (2014-2022) ($MN)
Table 38 GLOBAL PCR SERVICES MARKET, BY REGION, (2014-2022) ($MN)
Table 39 PCR TECHNOLOGIES GLOBAL MARKET, BY APPLICATIONS, (2014-2022) ($MN)
Table 40 GLOBAL PCR CLINICAL DIAGNOSTICS APPLICATION MARKET, BY REGION, (2014-2022) ($MN)
Table 41 GLOBAL PCR CLINICAL DIAGNOSTICS APPLICATION MARKET, BY TYPE, (2014-2022) ($MN)
Table 42 PCR CLINICAL DIAGNOSTICS INFECTIOUS MARKET, BY REGION, (2014-2022) ($MN)
Table 43 PCR CLINICAL DIAGNOSTICS INFECTIOUS MARKET, BY TYPE, (2014-2022) ($MN)
Table 44 PCR HEPATITIS B AND C TESTING MARKET, BY REGION, (2014-2022) ($MN)
Table 45 GLOBAL PCR TUBERCULOSIS DIAGNOSIS MARKET, BY REGION, (2014-2022) ($MN)
Table 46 GLOBAL PCR HIV DIAGNOSIS MARKET, BY REGION, (2014-2022) ($MN)
Table 47 GLOBAL PCR OTHER INFECTIOUS APPLICATIONS MARKET, BY REGION, (2014-2022) ($MN)
Table 48 GLOBAL PCR CLINICAL DIAGNOSTICS NON INFECTIOUS DISEASE MARKET, BY REGION, (2014-2022) ($MN)
Table 49 GLOBAL PCR CLINICAL DIAGNOSTICS NON INFECTIOUS DISEASE MARKET, BY TYPE, (2014-2022) ($MN)
Table 50 GLOBAL PCR PRENATAL DIAGNOSIS MARKET, BY REGION, (2014-2022) ($MN)
Table 51 GLOBAL PCR TISSUE TYPING/TRANSPLANT MARKET, BY REGION, (2014-2022) ($MN)
Table 52 GLOBAL PCR CANCER THERAPY AND DETERMINATION MARKET, BY REGION, (2014-2022) ($MN)
Table 53 GLOBAL PCR GENETIC TESTING FOR HEREDITORY DISEASE MARKET, BY REGION, (2014-2022) ($MN)
Table 54 GLOBAL PCR BLOOD SCREENING MARKET, BY REGION (2014-2022) ($MN)
Table 55 GLOBAL PCR OTHER NON INFECTIOUS APPLICATIONS MARKET, BY REGION, (2014-2022) ($MN)
Table 56 GLOBAL PCR BASED INDUSTRIAL APPLICATIONS MARKET, BY REGION, (2014-2022) ($MN)
Table 57 GLOBAL PCR BASED INDUSTRIAL APPLICATIONS MARKET, BY TYPE, (2014-2022) ($MN)
Table 58 GLOBAL PCR BASED AGRICULTURAL BIOTECHNOLOGY APPLICATIONS MARKET, BY REGION, (2014-2022) ($MN)
Table 59 GLOBAL PCR BASED ENVIRONMENTAL APPLICATIONS MARKET, BY REGION, (2014-2022) ($MN)
Table 60 GLOBAL PCR BASED APPLIED TESTING APPLICATIONS MARKET, BY REGION, (2014-2022) ($MN)
Table 61 GLOBAL PCR BASED APPLIED TESTING APPLICATIONS MARKET, BY TYPE, (2014-2022) ($MN)
Table 62 GLOBAL PCR BASED FORENSICS APPLICATIONS MARKET, BY REGION, (2014-2022) ($MN)
Table 63 GLOBAL PCR BASED FOOD SAFETY TESTING APPLICATIONS MARKET, BY REGION, (2014-2022) ($MN)
Table 64 GLOBAL PCR BASED ANIMAL HUSBANDRY APPLICATIONS MARKET, BY REGION, (2014-2022) ($MN)
Table 65 GLOBAL PCR BASED BIOMEDICAL APPLICATIONS MARKET, BY REGION, (2014-2022) ($MN)
Table 66 GLOBAL PCR BASED BIOMEDICAL RESEARCH APPLICATIONS MARKET, BY TYPE, (2014-2022) ($MN)
Table 67 GLOBAL PCR BASED DNA SEQUENCING APPLICATIONS MARKET, BY REGION, (2014-2022) ($MN)
Table 68 GLOBAL PCR BASED GENOTYPING APPLICATIONS MARKET, BY REGION, (2014-2022) ($MN)
Table 69 GLOBAL PCR BASED BIOMARKER DISCOVERY APPLICATIONS MARKET, BY REGION, (2014-2022) ($MN)
Table 70 GLOBAL PCR BASED GENE EXPRESSION & GENETIC MAPPING APPLICATIONS MARKET, BY REGION, (2014-2022) ($MN)
Table 71 GLOBAL PCR BASED DNA CLONING APPLICATIONS MARKET, BY REGION, (2014-2022) ($MN)
Table 72 GLOBAL PCR BASED OTHER BIOMEDICAL RESEARCH APPLICATIONS MARKET, BY REGION, (2014-2022) ($MN)
Table 73 GLOBAL PCR BASED OTHER INDUSTRIAL APPLICATIONS MARKET, BY REGION, (2014-2022) ($MN)
Table 74 GLOBAL PCR OTHER APPLICATIONS MARKET, BY REGION, (2014-2022) ($MN)
Table 75 GLOBAL PCR TECHNOLOGIES MARKET REVENUE, BY END-USER, (2014-2022) ($MN)
Table 76 GLOBAL PCR HOSPITAL AND LABORATORY END USERS MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 77 GLOBAL PCR PHARMACEUTICALS, CRO’S AND BIOTECH COMPANIES END USERS PCR MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 78 GLOBAL PCR ACADEMICS END USERS MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 79 GLOBAL PCR OTHERS END USERS MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 80 GLOBAL PCR TECHNOLOGIES MARKET, BY REGION, (2014–2022) ($MN)
Table 81 NORTH AMERICAN PCR TECHNOLOGIES MARKET, BY TECHNIQUE, (2014-2022) ($MN)
Table 82 NORTH AMERICAN PCR TECHNOLOGIES MARKET, BY PRODUCT, (2014-2022) ($MN)
Table 83 NORTH AMERICAN PCR INSTRUMENTS MARKET, BY TYPE, (2014-2022) ($MN)
Table 84 NORTH AMERICAN PCR REAGENTS MARKET, BY TYPE, (2014-2022) ($MN)
Table 85 NORTH AMERICAN PCR SOFTWARE MARKET, BY TYPE, (2014-2022) ($MN)
Table 86 NORTH AMERICAN PCR TECHNOLOGIES MARKET, BY APPLICATION, (2014-2022) ($MN)
Table 87 NORTH AMERICAN PCR CLINICAL DIAGNOSTIC APPLICATION MARKET, BY TYPE (2014-2022) ($MN)
Table 88 NORTH AMERICAN PCR CLINICAL DIAGNOSTICS INFECTIOUS MARKET, BY TYPE, (2014-2022) ($MN)
Table 89 NORTH AMERICAN PCR CLINICAL DIAGNOSTICS NON INFECTIOUS MARKET, BY TYPE, (2014-2022) ($MN)
Table 90 NORTH AMERICAN PCR INDUSTRY APPLICATION MARKET, BY TYPE, (2014-2022) ($MN)
Table 91 NORTH AMERICANPCR APPLIED TESTING APPLICATION MARKET, BY TYPE, (2014-2022) ($MN)
Table 92 NORTH AMERICANPCR BIOMEDICAL RESEARCH APPLICATION MARKET, BY TYPE, (2014-2022) ($MN)
Table 93 NORTH AMERICAN PCR TECHNOLOGIES MARKET, BY END-USER, (2014-2022) ($MN)
Table 94 EUROPEAN PCR MARKET REVENUE, BY TECHNIQUE, (2014-2022) ($MN)
Table 95 EUROPEAN PCR MARKET REVENUE, BY PRODUCTS, (2014-2022) ($MN)
Table 96 EUROPEAN PCR INSTRUMENTS MARKET, BY TYPE, (2014-2022) ($MN)
Table 97 EUROPEAN PCR REAGENTS MARKET, BY TYPE, (2014-2022) ($MN)
Table 98 EUROPEAN PCR SOFTWARE MARKET, BY TYPE, (2014-2022) ($MN)
Table 99 EUROPEAN PCR TECHNOLOGIES MARKET, BY APPLICATIONS, (2014-2022) ($MN)
Table 100 EUROPEAN PCR CLINICAL DIAGNOSTIC APPLICATION MARKET, BY TYPE, (2014-2022) ($MN)
Table 101 EUROPEAN PCR CLINICAL DIAGNOSTICS INFECTIOUS MARKET, BY TYPE, (2014-2022) ($MN)
Table 102 EUROPEAN PCR CLINICAL DIAGNOSTICS NON INFECTIOUS MARKET, BY TYPE, (2014-2022) ($MN)
Table 103 EUROPEAN PCR INDUSTRY APPLICATION MARKET, BY TYPE, (2014-2022) ($MN)
Table 104 EUROPEAN PCR APPLIED TESTING APPLICATION MARKET, BY TYPE, (2014-2022) ($MN)
Table 105 EUROPEAN PCR BIOMEDICAL RESEARCH APPLICATION MARKET, BY TYPE, (2014-2022) ($MN)
Table 106 EUROPEAN PCR TECHNOLOGIES MARKET, BY END-USER, (2014-2022) ($MN)
Table 107 ASIA PACIFIC PCR TECHNOLOGIES MARKET REVENUE, BY TECHNIQUE, (2014-2022) ($MN)
Table 108 ASIA PACIFIC PCR TECHNOLOGIES MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 109 ASIA PACIFIC PCR INSTRUMENTS MARKET, BY TYPE, (2014-2022) ($MN)
Table 110 ASIA PACIFIC PCR REAGENTS MARKET, BY TYPE, (2014-2022) ($MN)
Table 111 ASIA PACIFIC PCR SOFTWARE MARKET, BY TYPE, (2014-2022) ($MN)
Table 112 ASIA PACIFIC PCR TECHNOLOGIES MARKET, BY APPLICATIONS, (2014-2022) ($MN)
Table 113 ASIA PACIFIC PCR CLINICAL DIAGNOSTIC APPLICATION MARKET, BY TYPE (2014-2022) ($MN)
Table 114 ASIA PACIFIC PCR CLINICAL DIAGNOSTICS INFECTIOUS MARKET, BY TYPE, (2014-2022) ($MN)
Table 115 ASIA PACIFIC PCR CLINICAL DIAGNOSTICS NON INFECTIOUS MARKET, BY TYPE, (2014-2022) ($MN)
Table 116 ASIA PACIFIC PCR INDUSTRY APPLICATION MARKET, BY TYPE, (2014-2022) ($MN)
Table 117 ASIA PACIFIC PCR APPLIED TESTING APPLICATION MARKET, BY TYPE, (2014-2022) ($MN)
Table 118 ASIA PACIFIC PCR BIOMEDICAL RESEARCH APPLICATION MARKET, BY TYPE (2014-2022) ($MN)
Table 119 ASIA PACIFIC PCR TECHNOLOGIES MARKET, BY END-USER, (2014-2022) ($MN)
Table 120 ROW PCR TECHNOLOGIES MARKET REVENUE, BY TECHNIQUE, (2014-2022) ($MN)
Table 121 ROW PCR TECHNOLOGIES MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 122 ROW PCR INSTRUMENTS MARKET, BY TYPE, (2014-2022) ($MN)
Table 123 ROW PCR REAGENTS MARKET, BY TYPE, (2014-2022) ($MN)
Table 124 ROW PCR SOFTWARE MARKET, BY TYPE, (2014-2022) ($MN)
Table 125 ROW PCR TECHNOLOGIES MARKET, BY APPLICATION, (2014-2022) ($MN)
Table 126 ROW PCR CLINICAL DIAGNOSTIC APPLICATION MARKET, BY TYPE, (2014-2022) ($MN)
Table 127 ROW PCR CLINICAL DIAGNOSTICS INFECTIOUS MARKET, BY TYPE, (2014-2022) ($MN)
Table 128 ROW PCR CLINICAL DIAGNOSTICS NON INFECTIOUS MARKET, BY TYPE, (2014-2022) ($MN)
Table 129 ROW PCR INDUSTRY APPLICATION MARKET, BY TYPE, (2014-2022) ($MN)
Table 130 ROW PCR APPLIED TESTING APPLICATION MARKET, BY TYPE, (2014-2022) ($MN)
Table 131 ROW PCR BIOMEDICAL RESEARCH APPLICATION MARKET, BY TYPE, (2014-2022) ($MN)
Table 132 ROW PCR TECHNOLOGIES MARKET, BY END-USER, (2014-2022) ($MN)
Table 133 NEW PRODUCT LAUNCH (2014-2016)
Table 134 APPROVALS (2014-2016)
Table 135 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES (2014-2016)
Table 136 MERGERS AND ACQUISITION (2014-2016)
Table 137 OTHERS (2014-2016)
Table 138 ABBOTT LABORATORIES, INC.: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 139 ABBOTT LABORATORIES, INC.: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
Table 140 ABBOTT LABORATORIES, INC.: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 141 AGILENT TECHNOLOGIES: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 142 AGILENT TECHNOLOGIES: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
Table 143 AGILENT TECHNOLOGIES: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 144 BECTON DICKINSON AND COMPANY: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 145 BECTON DIKINSON AND COMPANY: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
Table 146 BECTON DIKINSON AND COMPANY: TOTAL REVENUE, BY LIFE SCIENCE SEGMENTS, (2013-2015) ($MN)
Table 147 BECTON DICKINSON AND COMPANY: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 148 BIOMERIEUX: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 149 BIOMEURIEX: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
Table 150 BIOMEURIEX: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 151 BIO-RAD LABORATORIES: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 152 BIO-RAD LABORATORIES: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
Table 153 BIO-RAD LABORATORIES: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 154 GE HEALTHCARE: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 155 GE HEALTHCARE: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
Table 156 GE HEALTHCARE: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 157 HOFFMANN-LA RACHE: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 158 HOFFMANN-LA ROCHE: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
Table 159 HOFFMANN-LA ROCHE’S: DIAGNOSTICS REVENUE, BY SEGMENTS (2013-2015) ($MN)
Table 160 HOFFMAN LA ROCHE: DIAGNOSTICS REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 161 MERCK KGAA: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 162 MERCK KGAA: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
Table 163 MERCK KGAA: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 164 PROMEGA CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2013-2014) ($MN)
Table 165 QIAGEN N.V.: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 166 QIAGEN N.V.: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
Table 167 QIAGEN N.V.: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 168 TAKARA BIO, INC.: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 169 TAKARA BIO, INC.: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
Table 170 TAKARA BIO INC.: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 171 THERMOFISHER SCIENTIFIC, INC.: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 172 THERMO FISHER SCIENTIFIC, INC.: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
Table 173 THERMO FISHER SCIENTIFIC, INC.: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 1 GLOBAL PCR TECHNOLOGIES MARKET, BY REGION, (2014-2022) ($MN)
Table 2 GLOBAL PCR TECHNOLOGIES MARKET, BY TECHNIQUES, (2014-2022) ($MN)
Table 3 GLOBAL PCR TECHNOLOGIES MARKET, BY PRODUCTS, (2014-2022) ($MN)
Table 4 GLOBAL PCR TECHNOLOGIES MARKET, BY APPLICATIONS, (2014-2022) ($MN)
Table 5 GLOBAL PCR TECHNOLOGIES MARKET , BY END-USERS, (2014-2022) ($MN)
Table 6 PCR GLOBAL MARKET , BY TECHNIQUES (2014-2022) ($MN)
Table 7 GLOBAL STANDARD PCR MARKET, BY GEOGRAPHY (2014-2022) ($MN)
Table 8 LIST OF INSTRUMENTS WITH COST AND FEATURES
Table 9 GLOBAL REAL TIME PCR/QPCR MARKET, BY GEOGRAPHY, (2014-2022) ($MN)
Table 10 GLOBAL REVERSE TRANSCRIPTASE PCR MARKET, BY GEOGRAPHY, (2014-2022) ($MN)
Table 11 LIST OF INSTRUMENTS AND THEIR COST FOR REACTION
Table 12 GLOBAL DIGITAL PCR MARKET, BY GEOGRAPHY, (2014-2022) ($MN)
Table 13 GLOBAL ASSEMBLY PCR MARKET, BY GEOGRAPHY, (2014-2022) ($MN)
Table 14 GLOBAL MULTIPLEX PCR MARKET, BY GEOGRAPHY (2014-2022) ($MN)
Table 15 GLOBAL HOT START PCR MARKET, BY GEOGRAPHY, (2014-2022) ($MN)
Table 16 GLOBAL OTHER PCR TECHNIQUES MARKET, BY GEOGRAPHY, (2014-2022) ($MN)
Table 17 GLOBAL PCR TECHNOLOGIES MARKET, BY PRODUCT TYPE, (2014-2022) ($MN)
Table 18 GLOBAL PCR INSTRUMENTS MARKET, BY REGION, (2014-2022) ($MN)
Table 19 GLOBAL PCR INSTRUMENTS MARKET, BY TYPE, (2014-2022) ($MN)
Table 20 GLOBAL PCR TRADITIONAL THERMOCYCLERS MARKET, BY REGION, (2014-2022) ($MN)
Table 21 GLOBAL PCR REAL TIME THERMOCYCLERS MARKET, BY REGION, (2014-2022) ($MN)
Table 22 GLOBAL PCR REAGENTS & CONSUMABLES MARKET, BY REGION, (2014-2022) ($MN)
Table 23 GLOBAL PCR REAGENTS & CONSUMABLES MARKET, BY TYPE, (2014-2022) ($MN)
Table 24 GLOBAL PCR ENZYMES MARKET, BY REGION, (2014-2022) ($MN)
Table 25 GLOBAL PCR DNTP’S MARKET, BY REGION, (2014-2022) ($MN)
Table 26 GLOBAL PCR TEMPLATES OR CONTROLS MARKET, BY REGION, (2014-2022) ($MN)
Table 27 GLOBAL PCR PRIMERS AND PROBES MARKET, BY REGION, (2014-2022) ($MN)
Table 28 GLOBAL PCR BUFFERS MARKET, BY REGION, (2014-2022) ($MN)
Table 29 GLOBAL PCR REAGENT KITS OR MASTER MIXES MARKET, BY REGION, (2014-2022) ($MN)
Table 30 GLOBAL PCR NUCLEASE FREE MARKET, BY REGION, (2014-2022) ($MN)
Table 31 GLOBAL PCR CONSUMABLES MARKET, BY REGION, (2014-2022) ($MN)
Table 32 GLOBAL PCR OTHER REAGENTS & CONSUMABLES MARKET, BY REGION, (2014-2022) ($MN)
Table 33 GLOBAL PCR SOFTWARE MARKET, BY REGION, (2014-2022) ($MN)
Table 34 GLOBAL PCR SOFTWARE MARKET, BY TYPE (2014-2022) ($MN)
Table 35 GLOBAL PCR PRIMER DESIGN AND SEQUENCING SOFTWARE MARKET, BY REGION, (2014-2022) ($MN)
Table 36 GLOBAL PCR DATA ANALYZER SOFTWARE MARKET, BY REGION, (2014-2022) ($MN)
Table 37 GLOBAL PCR OTHER SOFTWARES MARKET, BY REGION, (2014-2022) ($MN)
Table 38 GLOBAL PCR SERVICES MARKET, BY REGION, (2014-2022) ($MN)
Table 39 PCR TECHNOLOGIES GLOBAL MARKET, BY APPLICATIONS, (2014-2022) ($MN)
Table 40 GLOBAL PCR CLINICAL DIAGNOSTICS APPLICATION MARKET, BY REGION, (2014-2022) ($MN)
Table 41 GLOBAL PCR CLINICAL DIAGNOSTICS APPLICATION MARKET, BY TYPE, (2014-2022) ($MN)
Table 42 PCR CLINICAL DIAGNOSTICS INFECTIOUS MARKET, BY REGION, (2014-2022) ($MN)
Table 43 PCR CLINICAL DIAGNOSTICS INFECTIOUS MARKET, BY TYPE, (2014-2022) ($MN)
Table 44 PCR HEPATITIS B AND C TESTING MARKET, BY REGION, (2014-2022) ($MN)
Table 45 GLOBAL PCR TUBERCULOSIS DIAGNOSIS MARKET, BY REGION, (2014-2022) ($MN)
Table 46 GLOBAL PCR HIV DIAGNOSIS MARKET, BY REGION, (2014-2022) ($MN)
Table 47 GLOBAL PCR OTHER INFECTIOUS APPLICATIONS MARKET, BY REGION, (2014-2022) ($MN)
Table 48 GLOBAL PCR CLINICAL DIAGNOSTICS NON INFECTIOUS DISEASE MARKET, BY REGION, (2014-2022) ($MN)
Table 49 GLOBAL PCR CLINICAL DIAGNOSTICS NON INFECTIOUS DISEASE MARKET, BY TYPE, (2014-2022) ($MN)
Table 50 GLOBAL PCR PRENATAL DIAGNOSIS MARKET, BY REGION, (2014-2022) ($MN)
Table 51 GLOBAL PCR TISSUE TYPING/TRANSPLANT MARKET, BY REGION, (2014-2022) ($MN)
Table 52 GLOBAL PCR CANCER THERAPY AND DETERMINATION MARKET, BY REGION, (2014-2022) ($MN)
Table 53 GLOBAL PCR GENETIC TESTING FOR HEREDITORY DISEASE MARKET, BY REGION, (2014-2022) ($MN)
Table 54 GLOBAL PCR BLOOD SCREENING MARKET, BY REGION (2014-2022) ($MN)
Table 55 GLOBAL PCR OTHER NON INFECTIOUS APPLICATIONS MARKET, BY REGION, (2014-2022) ($MN)
Table 56 GLOBAL PCR BASED INDUSTRIAL APPLICATIONS MARKET, BY REGION, (2014-2022) ($MN)
Table 57 GLOBAL PCR BASED INDUSTRIAL APPLICATIONS MARKET, BY TYPE, (2014-2022) ($MN)
Table 58 GLOBAL PCR BASED AGRICULTURAL BIOTECHNOLOGY APPLICATIONS MARKET, BY REGION, (2014-2022) ($MN)
Table 59 GLOBAL PCR BASED ENVIRONMENTAL APPLICATIONS MARKET, BY REGION, (2014-2022) ($MN)
Table 60 GLOBAL PCR BASED APPLIED TESTING APPLICATIONS MARKET, BY REGION, (2014-2022) ($MN)
Table 61 GLOBAL PCR BASED APPLIED TESTING APPLICATIONS MARKET, BY TYPE, (2014-2022) ($MN)
Table 62 GLOBAL PCR BASED FORENSICS APPLICATIONS MARKET, BY REGION, (2014-2022) ($MN)
Table 63 GLOBAL PCR BASED FOOD SAFETY TESTING APPLICATIONS MARKET, BY REGION, (2014-2022) ($MN)
Table 64 GLOBAL PCR BASED ANIMAL HUSBANDRY APPLICATIONS MARKET, BY REGION, (2014-2022) ($MN)
Table 65 GLOBAL PCR BASED BIOMEDICAL APPLICATIONS MARKET, BY REGION, (2014-2022) ($MN)
Table 66 GLOBAL PCR BASED BIOMEDICAL RESEARCH APPLICATIONS MARKET, BY TYPE, (2014-2022) ($MN)
Table 67 GLOBAL PCR BASED DNA SEQUENCING APPLICATIONS MARKET, BY REGION, (2014-2022) ($MN)
Table 68 GLOBAL PCR BASED GENOTYPING APPLICATIONS MARKET, BY REGION, (2014-2022) ($MN)
Table 69 GLOBAL PCR BASED BIOMARKER DISCOVERY APPLICATIONS MARKET, BY REGION, (2014-2022) ($MN)
Table 70 GLOBAL PCR BASED GENE EXPRESSION & GENETIC MAPPING APPLICATIONS MARKET, BY REGION, (2014-2022) ($MN)
Table 71 GLOBAL PCR BASED DNA CLONING APPLICATIONS MARKET, BY REGION, (2014-2022) ($MN)
Table 72 GLOBAL PCR BASED OTHER BIOMEDICAL RESEARCH APPLICATIONS MARKET, BY REGION, (2014-2022) ($MN)
Table 73 GLOBAL PCR BASED OTHER INDUSTRIAL APPLICATIONS MARKET, BY REGION, (2014-2022) ($MN)
Table 74 GLOBAL PCR OTHER APPLICATIONS MARKET, BY REGION, (2014-2022) ($MN)
Table 75 GLOBAL PCR TECHNOLOGIES MARKET REVENUE, BY END-USER, (2014-2022) ($MN)
Table 76 GLOBAL PCR HOSPITAL AND LABORATORY END USERS MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 77 GLOBAL PCR PHARMACEUTICALS, CRO’S AND BIOTECH COMPANIES END USERS PCR MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 78 GLOBAL PCR ACADEMICS END USERS MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 79 GLOBAL PCR OTHERS END USERS MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 80 GLOBAL PCR TECHNOLOGIES MARKET, BY REGION, (2014–2022) ($MN)
Table 81 NORTH AMERICAN PCR TECHNOLOGIES MARKET, BY TECHNIQUE, (2014-2022) ($MN)
Table 82 NORTH AMERICAN PCR TECHNOLOGIES MARKET, BY PRODUCT, (2014-2022) ($MN)
Table 83 NORTH AMERICAN PCR INSTRUMENTS MARKET, BY TYPE, (2014-2022) ($MN)
Table 84 NORTH AMERICAN PCR REAGENTS MARKET, BY TYPE, (2014-2022) ($MN)
Table 85 NORTH AMERICAN PCR SOFTWARE MARKET, BY TYPE, (2014-2022) ($MN)
Table 86 NORTH AMERICAN PCR TECHNOLOGIES MARKET, BY APPLICATION, (2014-2022) ($MN)
Table 87 NORTH AMERICAN PCR CLINICAL DIAGNOSTIC APPLICATION MARKET, BY TYPE (2014-2022) ($MN)
Table 88 NORTH AMERICAN PCR CLINICAL DIAGNOSTICS INFECTIOUS MARKET, BY TYPE, (2014-2022) ($MN)
Table 89 NORTH AMERICAN PCR CLINICAL DIAGNOSTICS NON INFECTIOUS MARKET, BY TYPE, (2014-2022) ($MN)
Table 90 NORTH AMERICAN PCR INDUSTRY APPLICATION MARKET, BY TYPE, (2014-2022) ($MN)
Table 91 NORTH AMERICANPCR APPLIED TESTING APPLICATION MARKET, BY TYPE, (2014-2022) ($MN)
Table 92 NORTH AMERICANPCR BIOMEDICAL RESEARCH APPLICATION MARKET, BY TYPE, (2014-2022) ($MN)
Table 93 NORTH AMERICAN PCR TECHNOLOGIES MARKET, BY END-USER, (2014-2022) ($MN)
Table 94 EUROPEAN PCR MARKET REVENUE, BY TECHNIQUE, (2014-2022) ($MN)
Table 95 EUROPEAN PCR MARKET REVENUE, BY PRODUCTS, (2014-2022) ($MN)
Table 96 EUROPEAN PCR INSTRUMENTS MARKET, BY TYPE, (2014-2022) ($MN)
Table 97 EUROPEAN PCR REAGENTS MARKET, BY TYPE, (2014-2022) ($MN)
Table 98 EUROPEAN PCR SOFTWARE MARKET, BY TYPE, (2014-2022) ($MN)
Table 99 EUROPEAN PCR TECHNOLOGIES MARKET, BY APPLICATIONS, (2014-2022) ($MN)
Table 100 EUROPEAN PCR CLINICAL DIAGNOSTIC APPLICATION MARKET, BY TYPE, (2014-2022) ($MN)
Table 101 EUROPEAN PCR CLINICAL DIAGNOSTICS INFECTIOUS MARKET, BY TYPE, (2014-2022) ($MN)
Table 102 EUROPEAN PCR CLINICAL DIAGNOSTICS NON INFECTIOUS MARKET, BY TYPE, (2014-2022) ($MN)
Table 103 EUROPEAN PCR INDUSTRY APPLICATION MARKET, BY TYPE, (2014-2022) ($MN)
Table 104 EUROPEAN PCR APPLIED TESTING APPLICATION MARKET, BY TYPE, (2014-2022) ($MN)
Table 105 EUROPEAN PCR BIOMEDICAL RESEARCH APPLICATION MARKET, BY TYPE, (2014-2022) ($MN)
Table 106 EUROPEAN PCR TECHNOLOGIES MARKET, BY END-USER, (2014-2022) ($MN)
Table 107 ASIA PACIFIC PCR TECHNOLOGIES MARKET REVENUE, BY TECHNIQUE, (2014-2022) ($MN)
Table 108 ASIA PACIFIC PCR TECHNOLOGIES MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 109 ASIA PACIFIC PCR INSTRUMENTS MARKET, BY TYPE, (2014-2022) ($MN)
Table 110 ASIA PACIFIC PCR REAGENTS MARKET, BY TYPE, (2014-2022) ($MN)
Table 111 ASIA PACIFIC PCR SOFTWARE MARKET, BY TYPE, (2014-2022) ($MN)
Table 112 ASIA PACIFIC PCR TECHNOLOGIES MARKET, BY APPLICATIONS, (2014-2022) ($MN)
Table 113 ASIA PACIFIC PCR CLINICAL DIAGNOSTIC APPLICATION MARKET, BY TYPE (2014-2022) ($MN)
Table 114 ASIA PACIFIC PCR CLINICAL DIAGNOSTICS INFECTIOUS MARKET, BY TYPE, (2014-2022) ($MN)
Table 115 ASIA PACIFIC PCR CLINICAL DIAGNOSTICS NON INFECTIOUS MARKET, BY TYPE, (2014-2022) ($MN)
Table 116 ASIA PACIFIC PCR INDUSTRY APPLICATION MARKET, BY TYPE, (2014-2022) ($MN)
Table 117 ASIA PACIFIC PCR APPLIED TESTING APPLICATION MARKET, BY TYPE, (2014-2022) ($MN)
Table 118 ASIA PACIFIC PCR BIOMEDICAL RESEARCH APPLICATION MARKET, BY TYPE (2014-2022) ($MN)
Table 119 ASIA PACIFIC PCR TECHNOLOGIES MARKET, BY END-USER, (2014-2022) ($MN)
Table 120 ROW PCR TECHNOLOGIES MARKET REVENUE, BY TECHNIQUE, (2014-2022) ($MN)
Table 121 ROW PCR TECHNOLOGIES MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 122 ROW PCR INSTRUMENTS MARKET, BY TYPE, (2014-2022) ($MN)
Table 123 ROW PCR REAGENTS MARKET, BY TYPE, (2014-2022) ($MN)
Table 124 ROW PCR SOFTWARE MARKET, BY TYPE, (2014-2022) ($MN)
Table 125 ROW PCR TECHNOLOGIES MARKET, BY APPLICATION, (2014-2022) ($MN)
Table 126 ROW PCR CLINICAL DIAGNOSTIC APPLICATION MARKET, BY TYPE, (2014-2022) ($MN)
Table 127 ROW PCR CLINICAL DIAGNOSTICS INFECTIOUS MARKET, BY TYPE, (2014-2022) ($MN)
Table 128 ROW PCR CLINICAL DIAGNOSTICS NON INFECTIOUS MARKET, BY TYPE, (2014-2022) ($MN)
Table 129 ROW PCR INDUSTRY APPLICATION MARKET, BY TYPE, (2014-2022) ($MN)
Table 130 ROW PCR APPLIED TESTING APPLICATION MARKET, BY TYPE, (2014-2022) ($MN)
Table 131 ROW PCR BIOMEDICAL RESEARCH APPLICATION MARKET, BY TYPE, (2014-2022) ($MN)
Table 132 ROW PCR TECHNOLOGIES MARKET, BY END-USER, (2014-2022) ($MN)
Table 133 NEW PRODUCT LAUNCH (2014-2016)
Table 134 APPROVALS (2014-2016)
Table 135 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES (2014-2016)
Table 136 MERGERS AND ACQUISITION (2014-2016)
Table 137 OTHERS (2014-2016)
Table 138 ABBOTT LABORATORIES, INC.: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 139 ABBOTT LABORATORIES, INC.: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
Table 140 ABBOTT LABORATORIES, INC.: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 141 AGILENT TECHNOLOGIES: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 142 AGILENT TECHNOLOGIES: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
Table 143 AGILENT TECHNOLOGIES: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 144 BECTON DICKINSON AND COMPANY: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 145 BECTON DIKINSON AND COMPANY: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
Table 146 BECTON DIKINSON AND COMPANY: TOTAL REVENUE, BY LIFE SCIENCE SEGMENTS, (2013-2015) ($MN)
Table 147 BECTON DICKINSON AND COMPANY: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 148 BIOMERIEUX: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 149 BIOMEURIEX: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
Table 150 BIOMEURIEX: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 151 BIO-RAD LABORATORIES: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 152 BIO-RAD LABORATORIES: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
Table 153 BIO-RAD LABORATORIES: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 154 GE HEALTHCARE: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 155 GE HEALTHCARE: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
Table 156 GE HEALTHCARE: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 157 HOFFMANN-LA RACHE: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 158 HOFFMANN-LA ROCHE: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
Table 159 HOFFMANN-LA ROCHE’S: DIAGNOSTICS REVENUE, BY SEGMENTS (2013-2015) ($MN)
Table 160 HOFFMAN LA ROCHE: DIAGNOSTICS REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 161 MERCK KGAA: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 162 MERCK KGAA: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
Table 163 MERCK KGAA: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 164 PROMEGA CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2013-2014) ($MN)
Table 165 QIAGEN N.V.: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 166 QIAGEN N.V.: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
Table 167 QIAGEN N.V.: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 168 TAKARA BIO, INC.: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 169 TAKARA BIO, INC.: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
Table 170 TAKARA BIO INC.: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 171 THERMOFISHER SCIENTIFIC, INC.: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 172 THERMO FISHER SCIENTIFIC, INC.: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
Table 173 THERMO FISHER SCIENTIFIC, INC.: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
LIST OF FIGURES
Figure 1 GLOBAL PCR MARKET SHARE AND REVENUE, BY REGION, (2014-2022) ($MN)
Figure 2 RESEARCH METHODOLOGY: POLYMERASE CHAIN REACTION (PCR) GLOBAL MARKET
Figure 3 POLYMERASE CHAIN REACTION (PCR) GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
Figure 4 POLYMERASE CHAIN REACTION (PCR) GLOBAL MARKET: FORECASTING MODEL
Figure 5 POLYMERASE CHAIN REACTION (PCR) GLOBAL MARKET: MARKET CRACKDOWN AND DATA TRIANGULATION
Figure 6 PCR MARKET: MARKET SEGMENTATION
Figure 7 MARKET DYNAMICS
Figure 8 PCR MARKET: PORTER’S ANALYSIS
Figure 9 PCR MARKET: SUPPLY CHAIN ANALYSIS
Figure 10 GLOBAL PCR MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2015 (%)
Figure 11 PCR TECHNOLOGIES MARKET: PATENT FILING BY MAJOR PLAYERS (2011-2016)
Figure 12 GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, (2015 V’S 2022), ($MN)
Figure 13 GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT, (2015 V’S 2022), ($MN)
Figure 14 GLOBAL PCR REAGENTS AND CONSUMABLES MARKET SHARE (2015), (%)
Figure 15 GLOBAL PCR SOFTWARE MARKET SHARE (2015 VS 2022), (%)
Figure 16 GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, (2014-2022) ($MN)
Figure 17 GLOBAL PCR CLINICAL DIAGNOSTIC APPLICATION MARKET SIZE, BY TYPE, (2014-2022) ($MN)
Figure 18 GLOBAL PCR CLINICAL DIAGNOSTIC INFECTIOUS MARKET SHARE BY TYPE, (2015 V’S 2022) (%)
Figure 19 GLOBAL PCR CLINICAL DIAGNOSTIC NON INFECTIOUS MARKET SIZE, BY TYPE, (2015) ($MN)
Figure 20 GLOBAL PCR INDUSTRIAL APPLICATION MARKET SHARE, (2015) (%)
Figure 21 GLOBAL PCR BIOMEDICAL RESEARCH APPLICATION MARKET SIZE, (2015 V’S 2022) ($MN)
Figure 22 GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY END USERS, (2014-2022) ($MN)
Figure 23 GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY REGION, (2014-2022) ($MN)
Figure 24 NORTH AMERICA PCR TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, PRODUCT, APPLICATION & END-USER, (2015 V’S 2022) ($MN)
Figure 25 EUROPEAN PCR TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, PRODUCT, APPLICATION & END-USER, (2015 V’S 2022) ($MN)
Figure 26 ASIA PACIFIC PCR TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, PRODUCT, APPLICATION & END-USER, (2015 V’S 2022) ($MN)
Figure 27 ROW PCR TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, PRODUCT, APPLICATION & END-USER, (2015 V’S 2022) ($MN)
Figure 28 KEY GROWTH STRATEGIES (2014-2016)
Figure 29 SWOT: ABBOTT LABORATORIES, INC.
Figure 30 SWOT: AGILENT TECHNOLOGIES
Figure 31 SWOT: BECTON DICKINSON AND COMPANY
Figure 32 SWOT: BIOMERIEUX
Figure 33 SWOT: BIO-RAD LABORATORIES
Figure 34 SWOT: GE HEALTHCARE
Figure 35 SWOT: HOFFMANN–LA ROCHE
Figure 36 SWOT: MERCK KGAA
Figure 37 SWOT: PROMEGA CORPORATION
Figure 38 SWOT: QIAGEN N.V.
Figure 39 SWOT: TAKARA BIO INC
Figure 40 SWOT: THERMO FISHER SCIENTIFIC
Figure 1 GLOBAL PCR MARKET SHARE AND REVENUE, BY REGION, (2014-2022) ($MN)
Figure 2 RESEARCH METHODOLOGY: POLYMERASE CHAIN REACTION (PCR) GLOBAL MARKET
Figure 3 POLYMERASE CHAIN REACTION (PCR) GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
Figure 4 POLYMERASE CHAIN REACTION (PCR) GLOBAL MARKET: FORECASTING MODEL
Figure 5 POLYMERASE CHAIN REACTION (PCR) GLOBAL MARKET: MARKET CRACKDOWN AND DATA TRIANGULATION
Figure 6 PCR MARKET: MARKET SEGMENTATION
Figure 7 MARKET DYNAMICS
Figure 8 PCR MARKET: PORTER’S ANALYSIS
Figure 9 PCR MARKET: SUPPLY CHAIN ANALYSIS
Figure 10 GLOBAL PCR MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2015 (%)
Figure 11 PCR TECHNOLOGIES MARKET: PATENT FILING BY MAJOR PLAYERS (2011-2016)
Figure 12 GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, (2015 V’S 2022), ($MN)
Figure 13 GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT, (2015 V’S 2022), ($MN)
Figure 14 GLOBAL PCR REAGENTS AND CONSUMABLES MARKET SHARE (2015), (%)
Figure 15 GLOBAL PCR SOFTWARE MARKET SHARE (2015 VS 2022), (%)
Figure 16 GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, (2014-2022) ($MN)
Figure 17 GLOBAL PCR CLINICAL DIAGNOSTIC APPLICATION MARKET SIZE, BY TYPE, (2014-2022) ($MN)
Figure 18 GLOBAL PCR CLINICAL DIAGNOSTIC INFECTIOUS MARKET SHARE BY TYPE, (2015 V’S 2022) (%)
Figure 19 GLOBAL PCR CLINICAL DIAGNOSTIC NON INFECTIOUS MARKET SIZE, BY TYPE, (2015) ($MN)
Figure 20 GLOBAL PCR INDUSTRIAL APPLICATION MARKET SHARE, (2015) (%)
Figure 21 GLOBAL PCR BIOMEDICAL RESEARCH APPLICATION MARKET SIZE, (2015 V’S 2022) ($MN)
Figure 22 GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY END USERS, (2014-2022) ($MN)
Figure 23 GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY REGION, (2014-2022) ($MN)
Figure 24 NORTH AMERICA PCR TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, PRODUCT, APPLICATION & END-USER, (2015 V’S 2022) ($MN)
Figure 25 EUROPEAN PCR TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, PRODUCT, APPLICATION & END-USER, (2015 V’S 2022) ($MN)
Figure 26 ASIA PACIFIC PCR TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, PRODUCT, APPLICATION & END-USER, (2015 V’S 2022) ($MN)
Figure 27 ROW PCR TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, PRODUCT, APPLICATION & END-USER, (2015 V’S 2022) ($MN)
Figure 28 KEY GROWTH STRATEGIES (2014-2016)
Figure 29 SWOT: ABBOTT LABORATORIES, INC.
Figure 30 SWOT: AGILENT TECHNOLOGIES
Figure 31 SWOT: BECTON DICKINSON AND COMPANY
Figure 32 SWOT: BIOMERIEUX
Figure 33 SWOT: BIO-RAD LABORATORIES
Figure 34 SWOT: GE HEALTHCARE
Figure 35 SWOT: HOFFMANN–LA ROCHE
Figure 36 SWOT: MERCK KGAA
Figure 37 SWOT: PROMEGA CORPORATION
Figure 38 SWOT: QIAGEN N.V.
Figure 39 SWOT: TAKARA BIO INC
Figure 40 SWOT: THERMO FISHER SCIENTIFIC
